Swansea manager Roberto Martinez was delighted with his acquisition - whose contract is believed to be for at least two years - and says Bodde has the quality to take the club forward.
Coronary device maker Boston Scientific (nyse: BSX - news - people) is suing its partner, stent supplier and acquisition target Medinol for fraud and breach of contract.